From the website, the results of testing against the Gyrus system show that LTC, as currently FDA approved for duct sealing, is better than the competition. But not monumentally better. And clearly not so much better that surgeons and hospitals are ready to throw out their current equipment for what LTC can offer.
The real difference in LTC is the promise of organ welding. Proving this up will cost 10's if not 100's of millions in clinical trials. It will also take years. DR has neither.
We need a buyer for the whole of LTC. Attempting to bring LTC to market without a partner, if that's DR intended, was a huge miscalculation. And given the amount of time we waited for FDA approval, a JV deal should have been negotiated, contingent on FDA approval.
WTF is/was Richard on the BOD for if not this?
